लोराटाडीन के इंटरैक्शन

हम जिन FDA लेबल और फैक्ट शीट को इंडेक्स करते हैं, उनमें लोराटाडीन (Claritin, Alavert; एंटीहिस्टामिन) के 76 इंटरैक्शन दर्ज हैं: 7 गंभीर, 29 मध्यम, 39 मामूली, और 1 ऐसे जिनमें लेबल बताता है कि कोई महत्वपूर्ण इंटरैक्शन नहीं है। नीचे की हर प्रविष्टि उस वाक्य को उद्धृत करती है जिस पर वह आधारित है। दवा का यह पेज एक शुरुआती बिंदु है, आपकी स्थिति के लिए कोई फ़ैसला नहीं।

लेबल से लिए गए इंटरैक्शन

गंभीर इंटरैक्शन (7)

  • ट्रैनिलसाइप्रोमिनMAO इनहिबिटरगंभीर

    These medicines are in some cold, hay fever or weight-loss medicines. sympathomimetic herbal medicines or dietary supplements antihistamines (allergy medicines) triptans buspirone carbamazepine dextromethorphan dopamine hydroxytryptophan and tryptophan levodopa and methyldopa meperidine rasagline resperine s-adenosyl-L-methionine (SAM-e) tapentadol tetrabenazin… (ट्रैनिलसाइप्रोमिन लेबल, बॉक्स्ड चेतावनी)

  • डेसलोराटाडीनएंटीहिस्टामिनगंभीर

    CLARINEX Tablets, RediTabs, and Oral Solution are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see Warnings and Precautions (5.1) and Adverse Reactions (6.2) ]. (डेसलोराटाडीन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • डॉक्सीलामिनएंटीहिस्टामिनगंभीर

    …glaucoma • trouble urinating due to an enlarged prostate gland Ask a doctor or pharmacist before use if you are taking • a sedative or any other sleep-aid • tranquilizers • any other antihistamines • any other drugs When using this product • avoid alcoholic beverages • do not drive a motor vehicle or operate machinery • take only at bedtime Stop use and ask a doctor… (डॉक्सीलामिन लेबल, चेतावनियां)

  • डॉक्सीलामिन और पाइरिडोक्सिनएंटीहिस्टामिनगंभीर

    …hydrochloride delayed-release tablets are contraindicated in women with any of the following conditions: Known hypersensitivity to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride or any inactive ingredient in the formulation Monoamine oxidase (MAO) inhibitors intensify and prolong the adverse central nervous system effects… (डॉक्सीलामिन और पाइरिडोक्सिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • परफेनाज़िनएंटीसाइकोटिकगंभीर

    …contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown hypersensitivity to perphenazine products, their… (परफेनाज़िन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • पिटोलिसेंटQT अंतराल बढ़ाने वाली दवागंभीर

    Prevention or Management: Avoid centrally acting H1 receptor antagonists. (पिटोलिसेंट लेबल, दवाओं के इंटरैक्शन)

  • मोएक्सिप्रिलACE इनहिबिटरगंभीर

    None of the cases were considered life-threatening and all resolved either without treatment or with medication (antihistamines or glucocorticoids). (मोएक्सिप्रिल लेबल, चेतावनियां)

मध्यम इंटरैक्शन (29)

  • आइसोप्रेनालिनबीटा-एड्रीनर्जिक एगोनिस्टमध्यम

    Drugs that may potentiate clinical response of Isoproterenol Clinical Impact The effects of isoproterenol may be potentiated by tricyclic antidepressants, monoamine oxidase inhibitors, levothyroxine sodium, and certain antihistamines, notably chlorpheniramine, tripelennamine, and diphenhydramine. (आइसोप्रेनालिन लेबल, दवाओं के इंटरैक्शन)

  • इन्फ्लिक्सिमैबइम्यूनोसप्रेसेंटमध्यम

    Medications for the treatment of hypersensitivity reactions (e.g., acetaminophen, antihistamines, corticosteroids and/or epinephrine) should be available for immediate use in the event of a reaction [see Dosage and Administration (2.10) and Adverse Reactions (6.1) ] . (इन्फ्लिक्सिमैब लेबल, चेतावनियां और सावधानियां)

  • इमैटिनिबCYP3A4 इनहिबिटरमध्यम

    In these instances, Gleevec was resumed at a dose lower than that at which the reaction occurred and some patients also received concomitant treatment with corticosteroids or antihistamines. (इमैटिनिब लेबल, चेतावनियां और सावधानियां)

  • एड्रेनालिनसिम्पैथोमिमेटिकमध्यम

    …arrhythmias [see Warnings and Precautions (5.6) and Adverse Reactions (6) ]. β-blockers, such as propranolol Cyclopropane or halogenated hydrocarbon anesthetics, such as halothane Antihistamines Thyroid hormones Diuretics Cardiac glycosides, such as digitalis glycosides Quinidine Drugs potentiating hypokalemic effects of epinephrine • Potassium depleting diuretics… (एड्रेनालिन लेबल, दवाओं के इंटरैक्शन)

  • एफाविरेंज़एंटीरेट्रोवायरलमध्यम

    Prophylaxis with appropriate antihistamines before initiating therapy with efavirenz in pediatric patients should be considered. (एफाविरेंज़ लेबल, चेतावनियां और सावधानियां)

  • एलिस्किरेनएंटीहाइपरटेंसिव (ब्लड प्रेशर की दवा)मध्यम

    Patients who experience these effects, even without respiratory distress, require prolonged observation and appropriate monitoring measures since treatment with antihistamines and corticosteroids may not be sufficient to prevent respiratory involvement. (एलिस्किरेन लेबल, चेतावनियां और सावधानियां)

  • एलेमटुज़ुमैबइम्यूनोसप्रेसेंटमध्यम

    Premedicate patients with an antihistamine and acetaminophen prior to each dose. (एलेमटुज़ुमैब लेबल, चेतावनियां और सावधानियां)

  • If a SCAR is not confirmed, VIJOICE may require dose modifications, topical or systemic corticosteroids, or oral antihistamine treatment as described in Table 4 [see Dosage and Administration (2.5)] . (एल्पेलिसिब लेबल, चेतावनियां और सावधानियां)

  • एस्टाज़ोलमबेंज़ोडायज़ेपिनमध्यम

    The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression. (एस्टाज़ोलम लेबल, दवाओं के इंटरैक्शन)

  • ओक्रेलिज़ुमैबइम्यूनोसप्रेसेंटमध्यम

    In multiple sclerosis (MS) clinical trials, all adult and pediatric patients who were treated with OCREVUS received premedication with methylprednisolone (or an equivalent steroid), and may have also received an antihistamine (all pediatric patients) and/or an analgesic/antipyretic to reduce the risk of infusion reactions prior to each infusion. (ओक्रेलिज़ुमैब लेबल, चेतावनियां और सावधानियां)

  • ओफ्लॉक्सासिनफ्लुओरोक्विनोलोनमध्यम

    Serious acute hypersensitivity reactions may require treatment with epinephrine and other resuscitative measures, including oxygen, intravenous fluids, antihistamines, corticosteroids, pressor amines, and airway management, as clinically indicated (see PRECAUTIONS and ADVERSE REACTIONS ). (ओफ्लॉक्सासिन लेबल, चेतावनियां)

  • Prior to the first BIZENGRI infusion, premedicate with a corticosteroid, an H1 antihistamine and acetaminophen to reduce the risk of IRRs [see Dosage and Administration (2.4) ]. (ज़ेनोक्यूटुज़ुमैब लेबल, चेतावनियां और सावधानियां)

  • टियोट्रोपियमएंटीकोलिनर्जिकमध्यम

    Concomitant Respiratory Medications SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled steroids, antihistamines, mucolytics, leukotriene modifiers, cromones, and anti-IgE treatment without increases in adverse reactions. (टियोट्रोपियम लेबल, दवाओं के इंटरैक्शन)

  • टेमाज़ेपामबेंज़ोडायज़ेपिनमध्यम

    The benzodiazepines, including temazepam, produce additive CNS-depressant effects when co-administered with other CNS depressants such as alcohol, barbiturates, antipsychotics, sedative/hypnotics, anxiolytics, antidepressants, narcotic analgesics, sedative antihistamines, anticonvulsants, and anesthetics. (टेमाज़ेपाम लेबल, दवाओं के इंटरैक्शन)

  • TORISEL should be used with caution in patients with known hypersensitivity to an antihistamine, or patients who cannot receive an antihistamine for other medical reasons. (टेम्सिरोलिमस लेबल, चेतावनियां और सावधानियां)

  • Other Drugs that Cause CNS Depression The concurrent use of diphenoxylate hydrochloride and atropine sulfate with other drugs that cause CNS depression (e.g., barbiturates, benzodiazepines, opioids, buspirone, antihistamines, muscle relaxants), may potentiate the effects of diphenoxylate hydrochloride and atropine sulfate (see WARNINGS ). (डाइफेनोक्सिलेट और एट्रोपिन लेबल, दवाओं के इंटरैक्शन)

  • डाइसाइक्लोमिनएंटीकोलिनर्जिकमध्यम

    …following agents may increase certain actions or side effects of anticholinergic drugs including dicyclomine hydrochloride: amantadine, antiarrhythmic agents of Class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents,… (डाइसाइक्लोमिन लेबल, दवाओं के इंटरैक्शन)

  • डायज़ेपामबेंज़ोडायज़ेपिनमध्यम

    …be given to the pharmacology of the agents employed particularly with compounds that may potentiate or be potentiated by the action of Valium, such as phenothiazines, antipsychotics, anxiolytics/sedatives, hypnotics, anticonvulsants, narcotic analgesics, anesthetics, sedative antihistamines, narcotics, barbiturates, MAO inhibitors and other antidepressants. (डायज़ेपाम लेबल, दवाओं के इंटरैक्शन)

  • डॉक्सेपिनट्राइसाइक्लिक एंटीडिप्रेसेंटमध्यम

    Potential additive effects when used in combination with CNS depressants or sedating antihistamines. (डॉक्सेपिन लेबल, चेतावनियां और सावधानियां)

  • ड्रोनाबिनोलकैनाबिनॉइडमध्यम

    Concomitant use of other drugs that cause dizziness, confusion, sedation, or somnolence such as CNS depressants may increase this effect (e.g., barbiturates, benzodiazepines, lithium, opioids, buspirone, scopolamine, antihistamines, tricyclic antidepressants, other anticholinergic agents, and muscle relaxants). (ड्रोनाबिनोल लेबल, चेतावनियां और सावधानियां)

  • ड्रोपेरिडोलडोपामिन एंटागोनिस्टमध्यम

    Possible pharmacodynamic interactions can occur between droperidol and potentially arrhythmogenic agents such as class I or III antiarrhythmics, antihistamines that prolong the QT interval, antimalarials, calcium channel blockers, neuroleptics that prolong the QT interval, and antidepressants. (ड्रोपेरिडोल लेबल, दवाओं के इंटरैक्शन)

  • बुडेसोनाइड और फॉर्मोटेरोलकॉर्टिकोस्टेरॉइडमध्यम

    In clinical studies, concurrent administration of budesonide and formoterol fumarate dihydrate and other drugs, such as short-acting beta 2 -agonists, intranasal corticosteroids, and antihistamines/decongestants has not resulted in an increased frequency of adverse reactions. (बुडेसोनाइड और फॉर्मोटेरोल लेबल, दवाओं के इंटरैक्शन)

  • Consider measures to prevent severe reactions, including antihistamines, antipyretics and corticosteroids in subsequent cycles in patients who have experienced Grade 1 or 2 infusion reactions. (बेंडामुस्टिन लेबल, चेतावनियां और सावधानियां)

  • In patients who experience mild or moderate IRRs, consider premedications, including antihistamines, corticosteroids, and antipyretics. (मार्गेटुक्सिमैब लेबल, चेतावनियां और सावधानियां)

  • मेफ्लोक्वीनमलेरिया-रोधी दवामध्यम

    Other Drugs that Prolong the QTc Interval Coadministration of other drugs known to alter cardiac conduction (e.g., anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H 1 -blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval. (मेफ्लोक्वीन लेबल, दवाओं के इंटरैक्शन)

  • Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (मोटिक्साफोर्टाइड लेबल, चेतावनियां और सावधानियां)

  • Even in those instances where swelling of only the tongue is involved, without respiratory distress, patients may require prolonged observation since treatment with antihistamines and corticosteroids may not be sufficient. (लिसिनोप्रिल और हाइड्रोक्लोरोथायज़ाइड लेबल, चेतावनियां)

  • स्कोपोलामाइन (हायोसिन)एंटीकोलिनर्जिकमध्यम

    Concomitant use of other drugs that cause central nervous system (CNS) adverse reactions (e.g., alcohol, sedatives, hypnotics, opiates, and anxiolytics) or have anticholinergic properties (e.g., other belladonna alkaloids, sedating antihistamines, meclizine, tricyclic antidepressants, and muscle relaxants) may increase this effect [see Drug Interactions ( 7.1 )] . (स्कोपोलामाइन (हायोसिन) लेबल, चेतावनियां और सावधानियां)

  • • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (हायल्यूरोनिडेज़ लेबल, दवाओं के इंटरैक्शन)

मामूली ज़िक्र (39)

  • Antihistamines and/or aspirin have been used for most mild to moderate cases. (आइवरमेक्टिन लेबल, चेतावनियां)

  • एनालाप्रिलACE इनहिबिटरमामूली

    Symptoms have not been relieved by antihistamines in these situations. (एनालाप्रिल लेबल, चेतावनियां और सावधानियां)

  • In instances where swelling has been confined to the face and lips the condition has generally resolved without treatment, although antihistamines have been useful in relieving symptoms. (एनालाप्रिल और हाइड्रोक्लोरोथायज़ाइड लेबल, चेतावनियां)

  • एनालाप्रिलैटACE इनहिबिटरमामूली

    In instances where swelling has been confined to the face and lips the condition has generally resolved without treatment, although antihistamines have been useful in relieving symptoms. (एनालाप्रिलैट लेबल, चेतावनियां)

  • एफाविरेंज़, लैमिवुडिन और टेनोफोविरएंटीरेट्रोवायरलमामूली

    Appropriate antihistamines and/or corticosteroids may improve the tolerability and hasten the resolution of rash. (एफाविरेंज़, लैमिवुडिन और टेनोफोविर लेबल, चेतावनियां और सावधानियां)

  • एरिथ्रोमाइसिनमैक्रोलाइड एंटीबायोटिकमामूली

    Erythromycin has been reported to significantly alter the metabolism of the nonsedating antihistamines terfenadine and astemizole when taken concomitantly. (एरिथ्रोमाइसिन लेबल, दवाओं के इंटरैक्शन)

  • If signs of hypersensitivity occur, e.g. anaphylactoid reaction or angioedema develops, discontinue the Activase infusion and promptly institute appropriate therapy (e.g., antihistamines, intravenous corticosteroids, epinephrine). (एल्टेप्लेज़ लेबल, चेतावनियां और सावधानियां)

  • ऑक्सासिलिनपेनिसिलिन एंटीबायोटिकमामूली

    If an allergic reaction occurs, the drug should be discontinued and the patient should receive supportive treatment, e.g. , artificial maintenance of ventilation, pressor amines, antihistamines, and corticosteroids. (ऑक्सासिलिन लेबल, चेतावनियां)

  • ओलैंज़ापिन और फ्लुओक्सेटिनएंटीसाइकोटिकमामूली

    Most patients improved promptly with discontinuation of fluoxetine and/or adjunctive treatment with antihistamines or steroids, and all patients experiencing these reactions were reported to recover completely. (ओलैंज़ापिन और फ्लुओक्सेटिन लेबल, चेतावनियां और सावधानियां)

  • कार्बामाज़ेपिनएंटीकन्वल्सेंट (दौरे की दवा)मामूली

    …voriconazole ) , cimetidine, ciprofloxacin, clarithromycin, dalfopristin, danazol, dantrolene, delavirdine, diltiazem, erythromycin, fluoxetine, fluvoxamine, grapefruit juice, ibuprofen, isoniazid, loratadine, nefazodone, niacinamide, nicotinamide, olanzapine, omeprazole, oxybutynin, quinine, quinupristin, ticlopidine, troleandomycin, valproate, verapamil, zileuton. (कार्बामाज़ेपिन लेबल, दवाओं के इंटरैक्शन)

  • कैनाबिडियोल (प्रिस्क्रिप्शन दवा)एंटीकन्वल्सेंट (दौरे की दवा)मामूली

    Some subjects in the EPIDIOLEX clinical trials had pruritus, erythema, and angioedema requiring treatment, including corticosteroids and antihistamines. (कैनाबिडियोल (प्रिस्क्रिप्शन दवा) लेबल, चेतावनियां और सावधानियां)

  • क्विनाप्रिलACE इनहिबिटरमामूली

    In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms. (क्विनाप्रिल लेबल, चेतावनियां)

  • In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms. (क्विनाप्रिल और हाइड्रोक्लोरोथायज़ाइड लेबल, चेतावनियां)

  • ज़िप्रासिडोनएंटीसाइकोटिकमामूली

    Most patients improved promptly with adjunctive treatment with antihistamines or steroids and/or upon discontinuation of ziprasidone, and all patients experiencing these reactions were reported to recover completely. (ज़िप्रासिडोन लेबल, चेतावनियां और सावधानियां)

  • If symptoms of hypersensitivity occur, initiate appropriate therapy (e.g., antihistamines, corticosteroids, epinephrine). (टेनेक्टेप्लेज़ लेबल, चेतावनियां और सावधानियां)

  • ट्रैंडोलाप्रिलACE इनहिबिटरमामूली

    In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms. (ट्रैंडोलाप्रिल लेबल, चेतावनियां)

  • Prior to resumption of trastuzumab infusion, the majority of patients who experienced a severe infusion reaction were pre-medicated with antihistamines and/or corticosteroids. (ट्रैस्टुज़ुमैब लेबल, चेतावनियां और सावधानियां)

  • डेक्सट्रोएम्फेटामाइनCNS स्टिमुलेंटमामूली

    Antihistamines Amphetamines may counteract the sedative effect of antihistamines. (डेक्सट्रोएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

  • Pruritus and early rash may often be controlled by the concomitant administration of antihistamines. (पेनिसिलामिन लेबल, सावधानियां)

  • पेरैम्पेनलएंटीकन्वल्सेंट (दौरे की दवा)मामूली

    Patients should limit activity until they have experience with concomitant use of CNS depressants (e.g., benzodiazepines, narcotics, barbiturates, sedating antihistamines). (पेरैम्पेनल लेबल, दवाओं के इंटरैक्शन)

  • Most patients improved promptly with discontinuation of fluoxetine and/or adjunctive treatment with antihistamines or steroids, and all patients experiencing these reactions were reported to recover completely. (फ्लुओक्सेटिन लेबल, चेतावनियां और सावधानियां)

  • फ्लुनिसोलाइडकॉर्टिकोस्टेरॉइडमामूली

    Instead, nasal vasoconstrictors or oral antihistamines may be needed until the effects of flunisolide are fully manifested. (फ्लुनिसोलाइड लेबल, सावधानियां)

  • बेनाज़ेप्रिलACE इनहिबिटरमामूली

    Symptoms have not been relieved by antihistamines in these situations. (बेनाज़ेप्रिल लेबल, चेतावनियां और सावधानियां)

  • Discontinue in patients who develop a severe infusion-related reaction and administer appropriate medical therapy (e.g., epinephrine, corticosteroids, intravenous antihistamines, bronchodilators and/or oxygen). (बेवासिज़ुमैब लेबल, चेतावनियां और सावधानियां)

  • मेलफलानमामूली

    The infusion should be terminated immediately, followed by the administration of volume expanders, pressor agents, corticosteroids, or antihistamines at the discretion of the physician. (मेलफलान लेबल, चेतावनियां)

  • रिटुक्सिमैबइम्यूनोसप्रेसेंटमामूली

    Premedicate patients with an antihistamine and acetaminophen prior to dosing. (रिटुक्सिमैब लेबल, चेतावनियां और सावधानियां)

  • लिसिनोप्रिलACE इनहिबिटरमामूली

    Symptoms have not been relieved by antihistamines in these situations. (लिसिनोप्रिल लेबल, चेतावनियां और सावधानियां)

  • लेवोफ्लॉक्सासिनफ्लुओरोक्विनोलोनमामूली

    Serious acute hypersensitivity reactions may require treatment with epinephrine and other resuscitative measures, including oxygen, intravenous fluids, antihistamines, corticosteroids, pressor amines, and airway management, as clinically indicated [see Adverse Reactions ( 6 ) and Patient Counseling Information ( 17 )] . (लेवोफ्लॉक्सासिन लेबल, चेतावनियां और सावधानियां)

  • सिप्रोफ्लॉक्सासिनफ्लुओरोक्विनोलोनमामूली

    Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines, and airway management, including intubation, as indicated [see Adverse Reactions ( 6.1 , 6.2 )]. (सिप्रोफ्लॉक्सासिन लेबल, चेतावनियां और सावधानियां)

  • सेफडिनिरसेफालोस्पोरिनमामूली

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफडिनिर लेबल, चेतावनियां)

  • सेफपोडोक्सिमसेफालोस्पोरिनमामूली

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINE, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफपोडोक्सिम लेबल, चेतावनियां)

  • सेफप्रोज़िलसेफालोस्पोरिनमामूली

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफप्रोज़िल लेबल, चेतावनियां)

  • सेफाक्लोरसेफालोस्पोरिनमामूली

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफाक्लोर लेबल, चेतावनियां)

  • सेफाड्रोक्सिलसेफालोस्पोरिनमामूली

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफाड्रोक्सिल लेबल, चेतावनियां और सावधानियां)

  • सेफोटेटनसेफालोस्पोरिनमामूली

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफोटेटन लेबल, चेतावनियां)

  • सेफ्टाज़िडिमसेफालोस्पोरिनमामूली

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, IV FLUIDS, IV ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (सेफ्टाज़िडिम लेबल, चेतावनियां)

  • सेफ्ट्रिएक्सोनसेफालोस्पोरिनमामूली

    Serious acute hypersensitivity reactions may require treatment with epinephrine and other emergency measures including oxygen, corticosteroids, intravenous fluids, intravenous antihistamines, pressor amines, and airway management, as clinically indicated. (सेफ्ट्रिएक्सोन लेबल, चेतावनियां और सावधानियां)

  • सैक्यूबिट्रिल और वाल्सार्टनएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मामूली

    In cases of confirmed angioedema where swelling has been confined to the face and lips, the condition has generally resolved without treatment, although antihistamines have been useful in relieving symptoms. (सैक्यूबिट्रिल और वाल्सार्टन लेबल, चेतावनियां और सावधानियां)

  • हेपरिनएंटीकोएगुलेंट (खून पतला करने वाली दवा)मामूली

    Other Interactions Digitalis, tetracyclines, nicotine, or antihistamines, or intravenous nitroglycerin may partially counteract the anticoagulant action of heparin sodium. (हेपरिन लेबल, दवाओं के इंटरैक्शन)

कोई महत्वपूर्ण इंटरैक्शन नहीं बताया गया (1)

  • रोपिनिरोलडोपामिन एगोनिस्टकोई इंटरैक्शन नहीं

    Commonly Administered Drugs: Population analysis showed that commonly administered drugs (e.g., selegiline, amantadine, tricyclic antidepressants, benzodiazepines, ibuprofen, thiazides, antihistamines, anticholinergics) did not affect the clearance of ropinirole. (रोपिनिरोल लेबल, दवाओं के इंटरैक्शन)

आप जो कुछ भी लेते हैं, उस सबके साथ लोराटाडीन को जांचें। अपनी पूरी सूची जोड़ें; हर जोड़ी एक साथ जांची जाती है।

चेकर में खोलें

यह चिकित्सकीय सलाह नहीं है। गंभीरता लेबल के शब्दों को दर्शाती है, आपकी परिस्थितियों को नहीं। “गंभीर” चिह्न वाला संयोजन डॉक्टर की देखरेख में सामान्य बात हो सकता है, और “मामूली” चिह्न वाला संयोजन ऊंची खुराक पर मायने रख सकता है। फार्मासिस्ट से पूछें।